商品描述:
商品属性
编号:252396
化学名称:9(S)-(Dimethylaminomethyl)-6,7,10,11,19,20-hexahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20-dione monomethanesulfonate monohydrate
药物名称:Ruboxistaurin mesilate hydrate, LY-333531 mesylate hydrate
药理作用: Diabetic Neuropathy, Agents for, Diabetic Retinopathy, Agents for, ENDOCRINE DRUGS, OCULAR MEDICATIONS, ONCOLYTIC DRUGS, Ophthalmic Drugs, Treatment of Diabetic Complications, Inhibitors of Signal Transduction Pathways, Protein Kinase PKC beta Inhibitors
CAS号:202260-21-7, 192050-59-2 (anhydrous), 169939-94-0 (anhydrous free base), 286453-43-8 (hydrochloride hydrate), 286453-44-9 (hydrochloride hydrate), 202260-26-2 (L-tartrate), 202260-24-0 (monoacetate salt), 169939-93-9 (monoHCl), 202260-25-1 (phosphate (1:1
分子式:: C28-H28-N4-O3.C-H4-O3-S.H2-O
分子量582.6746
编号:252396
化学名称:9(S)-(Dimethylaminomethyl)-6,7,10,11,19,20-hexahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20-dione monomethanesulfonate monohydrate
药物名称:Ruboxistaurin mesilate hydrate, LY-333531 mesylate hydrate
药理作用: Diabetic Neuropathy, Agents for, Diabetic Retinopathy, Agents for, ENDOCRINE DRUGS, OCULAR MEDICATIONS, ONCOLYTIC DRUGS, Ophthalmic Drugs, Treatment of Diabetic Complications, Inhibitors of Signal Transduction Pathways, Protein Kinase PKC beta Inhibitors
CAS号:202260-21-7, 192050-59-2 (anhydrous), 169939-94-0 (anhydrous free base), 286453-43-8 (hydrochloride hydrate), 286453-44-9 (hydrochloride hydrate), 202260-26-2 (L-tartrate), 202260-24-0 (monoacetate salt), 169939-93-9 (monoHCl), 202260-25-1 (phosphate (1:1
分子式:: C28-H28-N4-O3.C-H4-O3-S.H2-O
分子量582.6746